Table 2.
Better QOL (n = 8) | Worse QOL (n = 14) | p-value† (comparison) | |
---|---|---|---|
Age, median (range) | 26.5 (20–37) | 31.5 (19–57) | 0.330 |
Female (%) | 87.5 | 85.7 | 1.000 |
Duration since onset, months, median (range) | 67 (26–153) | 90 (28–162) | 0.714 |
Tumor (%) | 37.5 | 50.0 | 0.675 |
Stay in ICU# (%) | 42.9 | 84.6 | 0.122 |
Use of ventilator (%) | 25.0 | 64.3 | 0.183 |
Favorable mRS (≤2) at present (%) | 100.0 | 71.4 | 0.254 |
Return to previous work/school life (%) | 100.0 | 57.1 | 0.051 |
Self-reliance at home life (%) | 100.0 | 64.3 | 0.115 |
Sequelae (%) | 0 | 71.4 | 0.002* |
Personality change (%) | 25.0 | 50.0 | 0.380 |
Relapse (%) | 25.0 | 21.4 | 1.000 |
QOL, quality of life; mRS, modified Rankin Scale; ICU, intensive care unit.
Statistically significant differences in clinical features and long-term outcomes between patients with better and worse QOL were tested using Fisher’s exact test for categorical data and the Mann–Whitney U test for numerical data, #two patients were excluded because they did not know whether they had stayed in ICU or not, *p < 0.05.